Table 1.
Overview of studies addressing the NADA protocol for behavioral health 2011–2016
First author/year | Study type | N | Population | Design | Treatment frequency | Outcome measures | Results | Comments |
---|---|---|---|---|---|---|---|---|
Carter/201146 | Prospective | 167 | Addiction in-patients | NADA + UC vs UC alone | NADA 2× per week for 4 weeks 30–45 min | Self-report 7 common BH symptoms, psychological, and physical | Positive, reduction in all symptoms vs UC | Self-selected not randomized |
Black/201147 | RCT | 140 | Addiction outpatients withdrawing from psychoactive drugs | NADA + UC vs sham + UC vs relaxation + UC | 3 NADA sessions; over 2 weeks, 45 min | STAI scale, heart rate, blood pressure pre- and posttests | Negative, reduction for all, no significant difference | All subjects in same room, no UC control, minimal treatment |
Janssen/201248 | RCT | 89 | Pregnant opiate dependent mothers and NAS in newborn infants | NADA + methadone vs methadone alone | Daily NADA sessions; 45 min | Number of days of treatment of newborn with morphine | Positive, decrease in number of days and NAS symptoms with NADA | Only 28% compliant with the NADA protocol |
Chang/201449 | RCT | 67 | Homeless veterans addiction program | NADA + UC, RR + UC, UC alone | NADA 2× per week for 10 weeks, 30 min | Cravings, anxiety | Positive, decrease in cravings and anxiety with both | Both equally effective vs UC |
Stuyt/201450 | Outcome | 231 | Dual diagnoses; 90-day inpatient treatment | NADA + UC vs UC | NADA 4–5× per week for 12 weeks; 45 min | Program completion, tobacco cessation, sobriety | Positive, NADA use correlated with positive outcomes | Self-selected not randomized |
Bergdahl/201454 | Qualitative | 15 | Addiction outpatients experiencing protracted withdrawal | Experience of NADA treatment during protracted withdrawal | NADA 2× per week for 5 weeks; 40 min | Positive and negative side effects, cravings, withdrawal symptoms | Positive, no major negative symptoms, improved positive symptoms | Very small; qualitative |
Reilly/201455 | Mixed methods | 37 | Health care providers in inpatient surgical burn/trauma ICU | Effects of NADA on reducing stress/anxiety in health care workers | 5 NADA sessions over 16-week period; 25 min | Pretest, posttest surveys, anxiety, burnout, compassion fatigue | Positive, significant improvement state/trait anxiety, burnout, compassion | Pre- and posttest design; self-selected, not randomized |
Bergdahl/201659 | RCT | 67 | Patients with chronic insomnia >6 months | NADA vs CBT-i | NADA 2× per week for 4 weeks; 45 min | ISI scores pre and posttests and 6 months follow-up | Positive, both resulted in decrease in ISI, but CBT-i was superior to NADA | Would be interesting to see the combination of both treatments |
DeLorent/201657 | Prospective parallel group clinical trial | 162 | Psychiatric patients with AD or MDD in UC | NADA vs PMR | NADA 2× per week for 4 weeks 30 min | VAS tension, anxiety, mood, anger, aggression | Positive, both showed improvement on all items | No control for UC |
Ahlberg/201658 | RCT | 280 | Addiction in inpatients and outpatients | NADA + UC vs LP + UC vs relaxation + UC | NADA 15× over 5 weeks; LP 10× over 4 weeks, same ear points | BAI and ISI pre and posttests and 3-month follow-up | Negative, no difference between NADA, LP, or relaxation control | No control for UC, high attrition, design concerns |
Abbreviations: NADA, National Acupuncture Detoxification Association; RCT, randomized-controlled trial; BH, behavioral health; STAI, Spielberger State–Trait Anxiety Inventory; UC, usual care; NAS, neonatal abstinence syndrome; ICU, intensive care unit; RR, relaxation response; AD, anxiety disorders; MDD, major depressive disorders; CBT-i, cognitive behavioral therapy-insomnia; ISI, Insomnia Severity Index; PMR, progressive muscle relaxation; VAS, visual analog scale; LP, local protocol; BAI, Beck Anxiety Inventory.